Oropharyngeal colostrum in preventing mortality and morbidity in preterm infants

Amna W. Nasuf; Shalini Ojha; Jon Dorling

doi:10.1002/14651858.CD011921

Oropharyngeal colostrum in preventing mortality and morbidity in preterm infants

Amna W. Nasuf, Shalini Ojha, Jon Dorling

Producción científica: Contribución a una revista › Artículo › revisión exhaustiva

55 Citas (Scopus)

Resumen

This is the protocol for a review and there is no abstract. The objectives are as follows: To determine if early (within the first 48 hours of life) oropharyngeal administration of mother’s own colostrum can reduce rates of NEC, late onset invasive infections, and/or mortality in preterm infants. We will also assess trials for evidence of harm and safety (e.g. aspiration pneumonia). We will compare the use of early OPC with no OPC use, placebo, late OPC use and nasogastric colostrum use.

Idioma original	English
Número de artículo	CD011921
Publicación	Cochrane Database of Systematic Reviews
Volumen	2015
N.º	10
DOI	https://doi.org/10.1002/14651858.CD011921
Estado	Published - oct. 20 2015
Publicado de forma externa	Sí

Nota bibliográfica

Funding Information:
• Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Department of Health and Human Services, USA. Editorial support of the Cochrane Neonatal Review Group has been funded with federal funds from the Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Department of Health and Human Services, USA, under Contract No. HHSN275201100016C

Publisher Copyright:
© 2015 The Cochrane Collaboration.

ASJC Scopus Subject Areas

Pharmacology (medical)

Acceder al documento

10.1002/14651858.CD011921

Otros archivos y enlaces

Citar esto

@article{fa4f8fd40dc04732bac0713b2227a0e7,

title = "Oropharyngeal colostrum in preventing mortality and morbidity in preterm infants",

abstract = "This is the protocol for a review and there is no abstract. The objectives are as follows: To determine if early (within the first 48 hours of life) oropharyngeal administration of mother{\textquoteright}s own colostrum can reduce rates of NEC, late onset invasive infections, and/or mortality in preterm infants. We will also assess trials for evidence of harm and safety (e.g. aspiration pneumonia). We will compare the use of early OPC with no OPC use, placebo, late OPC use and nasogastric colostrum use.",

author = "Nasuf, {Amna W.} and Shalini Ojha and Jon Dorling",

note = "Funding Information: • Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Department of Health and Human Services, USA. Editorial support of the Cochrane Neonatal Review Group has been funded with federal funds from the Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Department of Health and Human Services, USA, under Contract No. HHSN275201100016C Publisher Copyright: {\textcopyright} 2015 The Cochrane Collaboration.",

year = "2015",

month = oct,

day = "20",

doi = "10.1002/14651858.CD011921",

language = "English",

volume = "2015",

journal = "Cochrane Database of Systematic Reviews",

issn = "1361-6137",

publisher = "John Wiley and Sons Ltd",

number = "10",

}

TY - JOUR

T1 - Oropharyngeal colostrum in preventing mortality and morbidity in preterm infants

AU - Nasuf, Amna W.

AU - Ojha, Shalini

AU - Dorling, Jon

N1 - Funding Information: • Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Department of Health and Human Services, USA. Editorial support of the Cochrane Neonatal Review Group has been funded with federal funds from the Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Department of Health and Human Services, USA, under Contract No. HHSN275201100016C Publisher Copyright: © 2015 The Cochrane Collaboration.

PY - 2015/10/20

Y1 - 2015/10/20

N2 - This is the protocol for a review and there is no abstract. The objectives are as follows: To determine if early (within the first 48 hours of life) oropharyngeal administration of mother’s own colostrum can reduce rates of NEC, late onset invasive infections, and/or mortality in preterm infants. We will also assess trials for evidence of harm and safety (e.g. aspiration pneumonia). We will compare the use of early OPC with no OPC use, placebo, late OPC use and nasogastric colostrum use.

AB - This is the protocol for a review and there is no abstract. The objectives are as follows: To determine if early (within the first 48 hours of life) oropharyngeal administration of mother’s own colostrum can reduce rates of NEC, late onset invasive infections, and/or mortality in preterm infants. We will also assess trials for evidence of harm and safety (e.g. aspiration pneumonia). We will compare the use of early OPC with no OPC use, placebo, late OPC use and nasogastric colostrum use.

UR - http://www.scopus.com/inward/record.url?scp=85041672009&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85041672009&partnerID=8YFLogxK

U2 - 10.1002/14651858.CD011921

DO - 10.1002/14651858.CD011921

M3 - Article

AN - SCOPUS:85041672009

SN - 1361-6137

VL - 2015

JO - Cochrane Database of Systematic Reviews

JF - Cochrane Database of Systematic Reviews

IS - 10

M1 - CD011921

ER -

Oropharyngeal colostrum in preventing mortality and morbidity in preterm infants

Resumen

Nota bibliográfica

ASJC Scopus Subject Areas

Acceder al documento

Otros archivos y enlaces

Huella

Citar esto